spacer
home > ict > Autumn 2016
PUBLICATIONS

International Clinical Trials

ict
Autumn 2016

   
Text
PDF
Editor’s Comment

From risk-based monitoring to mHealth developments, this edition of ICT combines current topics in the clinical trial landscape. Graham Hughes comments on the most prevalent themes.
 
view
download pdf
bullet
Clinical Trial Management
Paperless Monitoring

Keeping Tabs

Jan Klint Nielsen
at BSI discusses the role of clinical trial management systems in the conduct of studies, and the positive effect they might have on trial operations as a whole.
 
view
download pdf
bullet
Clinical Trial Outsourcing
CRO-Pharma Collaboration

Does Size Really Matter?


Outsourcing is becoming an increasingly attractive option for pharma companies looking to delegate their trial operations. Mohamed El Malt at Europital reveals why choosing smaller CROs does not necessarily leave sponsors at a disadvantage.
 
view
download pdf
bullet
Clinical Trial Supply & Packaging
Clinical Supplies

Future Vision


Forecasting and simulations are, according to Praveen Chand at Cenduit, a reliable way of planning the near-exact amount of clinical supplies needed for a trial, which can help facilitate this complex task.
 
view
download pdf
Just-In-Time Labelling

A Question of Standards


Labelling drugs is as important as the package used to store them – with both playing a critical part in patient compliance, states Faubel Pharma Services’ Nurdan Citamak.
 
view
download pdf
bullet
Regional trials
Asia-Pacific Trials

Changing Face

PCI Clinical Services’ Rich Nelson
explains the increasing shift from conducting investigational studies in Western countries to the Asia- Pacific region, and highlights marked differences in regulatory and logistical risk.
 
view
download pdf
Regional Focus: India

Credibility Crisis


The reputation of Indian drug makers has been hit hard by rising levels of concern about their manufacturing practices, observes Vivek Chaturvedi at Hitachi Consulting. He examines possible reasons for these doubts.
 
view
download pdf
Clinical Trials in India

Making a Comeback


India is an attractive location for studies looking for access to a wider population base and ethnic diversity of potential subjects, among other benefits – yet a decline in CTA approvals is telling a different story. Pharm-Olam’s Thanuja Naidu outlines how regulatory authorities are addressing this issue.
 
view
download pdf
bullet
Ethics & Risk Management
Risk-Based Monitoring

What’s the Risk?


To improve subject safety and data quality in the drug development process, an RBM approach is required – which also helps to reduce costs, claim Greg Ambra and Jean Battikha at DZS Clinical Services.
 
view
download pdf
Human Factor Analysis

Lessons Learned


Clara Heering
at ICON believes that employing human factor analysis has the potential to radically improve trial efficiency through a better approach in the identification of risks and errors.
 
view
download pdf
bullet
Supply Chain & Manufacturing
Global Supply Chains

The Complete Journey

PAREXEL’s Andrea Zobel
takes us through the entire drug supply chain stages – from the initial planning and manufacturing, to distribution and dispensing to patients.
 
view
download pdf
End Point

Can You Resist?


ICT Editor Graham Hughes raises awareness about the fact that millions of lives are lost because of drug-resistant infections – but antibiotics are immensely difficult to produce.
 
view
download pdf

Patient Recruitment and Retention
Direct-to-Patient Model

Coming to You


World Courier’s Sue Lee
wonders if the concept of bringing the trial to the patient – rather than the other way around – could be the solution to ongoing recruitment and retention challenges.
 
view
download pdf
mHealth and Patient Engagement

Get Involved


Clinical Ink’s Kyle Hogan
investigates the connection between mobile devices, protocol compliance and patient retention.
 
view
download pdf

Interview
Q&A: Event Preview

Communication is Key

Naomi Brooker
talks to ICT about the main themes of the upcoming Partnerships in Clinical Trials Europe event in Vienna, Austria.
 
view
download pdf
bullet
Digital Advances
mHealth Solutions

Are You Mobile?

Nancy Mulligan
and Patrick Prugh at UBC comment on the growing prevalence of mobile technology and mHealth apps in pharma, and consider the question of how and when to incorporate these in clinical trials.
 
view
download pdf
Medication Adherence

Deliverapp

Chris Evans
at West Pharmaceutical Services contemplates mHealth apps in the context of medication adherence in chronic disease patients, and why they can prove beneficial.
 
view
download pdf
Electronic Health Records

The Patient Chronicle


To reach the common goal of more efficient healthcare systems, it is imperative to integrate technology into patient registers. Martin Gibson at NorthWest EHealth talks about the numerous advantages that electronic health records could bring.
 
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

EXTERNAL COMMUNICATION, 24 October 2019, Copenhagen, Denmark PRESS RELEASE – FLYPHARMA CONFERENCE EUROPE 2019

For its fifth annual Europe conference, FlyPharma chose Copenhagen as its host city to address the latest supply chain challenges and industry best practices, putting together a global audience of (bio)pharma and logistics professionals. The two-day conference (22-23 October 2019) aimed to discuss the collaboration and growth within Scandinavia, with a special focus on women in pharmaceutical logistics and an exploration of the industry’s digitalisation and innovation.
More info >>

White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>

Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement